Establishment of RPA-Cas12a-Based Fluorescence Assay for Rapid Detection of Feline Parvovirus

Pol J Microbiol. 2024 Mar 4;73(1):39-48. doi: 10.33073/pjm-2024-005. eCollection 2024 Mar 1.

Abstract

Feline parvovirus (FPV) is highly infectious for cats and other Felidae and often causes severe damage to young kittens. In this study, we incorporated recombinase polymerase amplification (RPA) and Cas12a-mediated detection and developed an RPA-Cas12a-based real-time or end-point fluorescence detection method to identify the NS1 gene of FPV. The total time of RPA-Cas12a-based fluorescence assay is approximately 25 min. The assay presented a limit of detection (LOD) of 1 copies/μl (25 copies/per reaction), with no cross-reactivity with several feline pathogens. The clinical performance of the assay was examined using total genomic DNA purified from 60 clinical specimens and then compared to results obtained with qPCR detection of FPV with 93.3% positive predictive agreement and 100% negative predictive agreement. Together, the rapid reaction, cost-effectiveness, and high sensitivity make the RPA-Cas12a-based fluorescence assay a fascinating diagnostic tool that will help minimize infection spread through instant detection of FPV.

Keywords: CRISPR-Cas12a; RPA; detection; feline parvovirus; real-time fluorescence.

MeSH terms

  • Animals
  • CRISPR-Cas Systems
  • Cats
  • Feline Panleukopenia Virus*
  • Female
  • Limit of Detection
  • Recombinases*

Substances

  • Recombinases

Grants and funding

This work was supported by Xi’an Science and Technology Plan Project (23LLRHZDZX0012, 22GXFW0007),, and Key Research and Development Plan Project in Shaanxi Province (2023-YBNY-170).